| CAS NO: | 1991986-30-1 |
| 规格: | 98% |
| 分子量: | 517.54 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
Background:
ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2), and can be used for the research of breast cancer, extracted from patent WO 2016134026 A1, compound Figure 10G.
[1]. Methods and materials for assessing chemotherapy responsiveness and treating cancer. WO 2016134026 A1
m.cnreagent.com